Taiwan FDA registration b7f08621edb98f0a108ef6e77fe20c3a
New speed speed test Bluetooth blood glucose test system
TW: 新速利測藍牙血糖測試系統
Taiwan·Risk Class 2·APEX BIOTECHNOLOGY CORPORATION·Registered Jan 11, 2022 – Jan 11, 2027ActiveRegistration details
- Analysis ID
- b7f08621edb98f0a108ef6e77fe20c3a
Company information
- Manufacturer
- APEX BIOTECHNOLOGY CORPORATION
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- APEX BIOTECHNOLOGY CORPORATION
Product details
- Intended Use
- This product is an in vitro diagnostic medical device used to quantitatively detect the blood glucose value of whole blood collected by fingertips, palms and forearms, and provides diabetic patients with home use and professional use.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- QMS/QSD;; 國產
Dates and status
- Registration Date
- Jan 11, 2022
- Expiry Date
- Jan 11, 2027
About this record
Access comprehensive regulatory information for New speed speed test Bluetooth blood glucose test system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number b7f08621edb98f0a108ef6e77fe20c3a and manufactured by APEX BIOTECHNOLOGY CORPORATION. The authorized representative in Taiwan is APEX BIOTECHNOLOGY CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices